Virios Therapeutics Llc Stock Current Ratio
| VIRI Stock | USD 0.51 0.03 6.25% |
Virios Therapeutics Llc fundamentals help investors to digest information that contributes to Virios Therapeutics' financial success or failures. It also enables traders to predict the movement of Virios Stock. The fundamental analysis module provides a way to measure Virios Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virios Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 11.62 | 7.04 |
Virios | Current Ratio |
Virios Therapeutics Llc Company Current Ratio Analysis
Virios Therapeutics' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Virios Therapeutics Current Ratio | 4.76 X |
Most of Virios Therapeutics' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virios Therapeutics Llc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Virios Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Virios Therapeutics is extremely important. It helps to project a fair market value of Virios Stock properly, considering its historical fundamentals such as Current Ratio. Since Virios Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Virios Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Virios Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Virios Current Ratio Historical Pattern
Today, most investors in Virios Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Virios Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Virios Therapeutics current ratio as a starting point in their analysis.
Virios Therapeutics Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Virios Therapeutics Llc has a Current Ratio of 4.76 times. This is 63.57% higher than that of the Biotechnology sector and 32.0% lower than that of the Health Care industry. The current ratio for all United States stocks is 120.37% lower than that of the firm.
Virios Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virios Therapeutics' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics of similar companies.Virios Therapeutics is currently under evaluation in current ratio category among related companies.
Virios Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Virios Therapeutics from analyzing Virios Therapeutics' financial statements. These drivers represent accounts that assess Virios Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Virios Therapeutics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 138.4M | 62.4M | 42.6M | 2.6M | 10.8M | 10.3M | |
| Enterprise Value | 141.7M | 32.6M | 28.6M | (4.4M) | 7.5M | 7.1M |
Virios Fundamentals
| Return On Equity | -0.95 | ||||
| Return On Asset | -0.54 | ||||
| Current Valuation | 6.55 M | ||||
| Shares Outstanding | 19.26 M | ||||
| Shares Owned By Insiders | 9.71 % | ||||
| Shares Owned By Institutions | 8.08 % | ||||
| Number Of Shares Shorted | 217.54 K | ||||
| Price To Book | 2.59 X | ||||
| EBITDA | (5.45 M) | ||||
| Net Income | (5.3 M) | ||||
| Cash And Equivalents | 7.7 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 4.15 M | ||||
| Current Ratio | 4.76 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (4.87 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 2.2 | ||||
| Beta | 1.88 | ||||
| Market Capitalization | 9.61 M | ||||
| Total Asset | 4.17 M | ||||
| Retained Earnings | (61.47 M) | ||||
| Working Capital | 3.81 M | ||||
| Net Asset | 4.17 M |
About Virios Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virios Therapeutics Llc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics Llc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Virios Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Virios Therapeutics' short interest history, or implied volatility extrapolated from Virios Therapeutics options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink |
Check out Virios Therapeutics Piotroski F Score and Virios Therapeutics Altman Z Score analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Virios Stock analysis
When running Virios Therapeutics' price analysis, check to measure Virios Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virios Therapeutics is operating at the current time. Most of Virios Therapeutics' value examination focuses on studying past and present price action to predict the probability of Virios Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virios Therapeutics' price. Additionally, you may evaluate how the addition of Virios Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Virios Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virios Therapeutics. If investors know Virios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virios Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Return On Assets (0.54) | Return On Equity (0.95) |
The market value of Virios Therapeutics Llc is measured differently than its book value, which is the value of Virios that is recorded on the company's balance sheet. Investors also form their own opinion of Virios Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Virios Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virios Therapeutics' market value can be influenced by many factors that don't directly affect Virios Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virios Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virios Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virios Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.